Back to Authors

Schmitz, Norbert

https://orcid.org/0000-0003-4938-7528

Mayo Clinic

University of Münster

Citations 13

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
King, Rebecca L. , Jiang, Aixiang , Horn, Heike , Mottok, Anja , Farinha, Pedro , Slack, Graham W. , Ennishi, Daisuke , Schmitz, Norbert , Pfreundschuh, Michael , Nowakowski, Grzegorz S. , Gascoyne, Randy D. , Ott, German , Macon, William R. , Rosenwald, Andreas , Scott, David W. , Staiger, Annette M. , Ben‐Neriah, Susana , Kahl, Brad S. , Connors, Joseph M. , Farinha, Pedro

Blood | February 23, 2018 | Volume: 131 | Issue: 18 | Pages: 2060-2064

10.1182/blood-2017-12-820605 Get It

Key Points HGBL-DH/TH makes up 8% of de novo DLBCL, with HGBL-DH/TH with BCL2 rearrangement being a GCB phenomenon. Restricting FISH testing to tumors with dual protein expression and GCB subtype results in testing <15% of tumors, but missing ∼35% of HGBL-DH/TH.
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
Shi, Qian , Flowers, Christopher R. , Schmitz, Norbert , Flament, Jocelyne, Coiffier, Bertrand , group, on behalf of the SEAL, Shi, Qian , Sargent, Daniel J. , Habermann, Thomas M. , Fu, Tommy , group, on behalf of the SEAL

The Oncologist | August 11, 2017 | Volume: 22 | Issue: 12 | Pages: 1415-1418

10.1634/theoncologist.2017-0177 Get It

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.
PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES
Nguyen, Dinh-Phong , Schmitz, Norbert , Lamant, Laurence , Weisenburger, Dennis D. , Ziepert, Marita , Bast, M., Tilly, H., Jaïs, Jean Philippe, Sibon, David , Suzuki, Ritsuro , Feldman, Andrew L. , Gressin, Rémy , Nakamura, Shôji , Maurer, Matthew J. , Armitage, Jamés O. , Vose, Julie M. , Savage, Kerry J.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 240-240

10.1002/hon.2438_103 Get It